On the contrary, laminA/C overexpression inhibited FGFR signaling while increasing c-fos binding to laminA/C, resulting in blocking of the evolution of acquired resistance associated with EMT in NSCLC with EGFR mutations (Figure 8). Here, FOS is linked to non-small cell lung carcinoma.